Geoffrey M. Parker's Net Worth
-$1.93 Million
Who is Geoffrey M. Parker?
Geoffrey M. Parker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Anacor Pharmaceuticals Inc, ChemoCentryx, Inc., GENOPTIX INC, Tricida, Inc., PERRIGO Co plc, SUNESIS PHARMACEUTICALS INC, Better Therapeutics, Inc., and GENOMIC HEALTH INC.
SEC CIK
Geoffrey M. Parker's CIK is 0001491874
Past Insider Trading and Trends
2011 was Geoffrey M. Parker's most active year for acquiring shares with 16 total transactions. Geoffrey M. Parker's most active month to acquire stocks was the month of April. 2019 was Geoffrey M. Parker's most active year for disposing of shares, totalling 12 transactions. Geoffrey M. Parker's most active month to dispose stocks was the month of April. 2018 saw Geoffrey M. Parker paying a total of $1,600,883.30 for 122,186 shares, this is the most they've acquired in one year. In 2013 Geoffrey M. Parker cashed out on 80,000 shares for a total of $400,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.12% | -36.40K |
$2.84 | -$103,387.36 | 1.13M |
Oct 21
| |||
Form 4
| +42.07% | 344.83K |
$2.90 | $1,000,001.20 | 1.16M |
May 16
| |||
Form 4
| +0.02% | 190 |
$3.60 | $683.05 | 819.59K |
Jan 30
| |||
Form 4
| +3.72% | 29.4K |
—
|
—
| 819.4K |
Jan 25
| |||
Form 4
|
∞
| 790K |
—
|
—
| 790K |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anacor Pharmaceuticals Inc No price found
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.76% | 3K |
$52.43 | $157,303.80 | 173K |
Mar 23
| |||
Form 4
| +7.77% | 6.84K |
—
|
—
| 94.84K |
Feb 3
| |||
Form 4
| +4.03% | 6.59K |
$21.82 | $143,807.04 | 170K |
Sep 5 - Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| +3.16% | 5K |
$20.11 | $100,533.00 | 163.41K |
Mar 24
| |||
Form 4
| +1.54% | 2.41K |
$22.60 | $54,469.37 | 158.41K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +6.85% | 10K |
$13.40 | $133,950.00 | 156K |
Nov 26
| |||
Form 4
| +7.35% | 10K |
$12.85 | $128,475.00 | 146K |
Nov 25
| |||
Form 4
| +1,600.00% | 80K |
$5.00 | $400,000.00 | 85K |
Oct 4
| |||
Form 4
| +58.14% | 50K |
$8.34 | $417,205.00 | 136K |
Aug 13
| |||
Form 4
| +36.61% | 23.05K |
$5.20 | $119,947.52 | 86K |
Jun 19
| |||
Form 4
| +37.77% | 20K |
$5.22 | $104,373.00 | 72.95K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
| +9.81% | 5K |
$6.19 | $30,955.50 | 55.95K |
Aug 22
| |||
Form 4
| +18.94% | 7.95K |
$4.81 | $38,294.59 | 49.95K |
Jun 4 - Jun 5
| |||
Form 4
| +31.25% | 10K |
$6.08 | $60,814.18 | 42K |
Mar 19 - Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +50.00% | 10K |
$5.95 | $59,532.33 | 30K |
May 23 - May 24
| |||
Form 4
|
∞
| 20K |
$6.17 | $123,374.15 | 20K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ChemoCentryx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -134.07K |
—
|
—
|
0
|
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +57.87% | 7.73K |
—
|
—
| 21.08K |
May 20
| |||
Form 4
| +11.17% | 12.5K |
$14.42 | $180,250.00 | 124.41K |
May 2
| |||
Form 4
| +5.20% | 660 |
—
|
—
| 13.35K |
Mar 10 - May 21
| |||
Form 4
| -71.55% | -31.91K |
$56.61 | -$1,806,448.44 | 12.69K |
Mar 4 - Mar 5
| |||
Form 4
| +7.41% | 7.72K |
—
|
—
| 111.91K |
May 21 - May 23
| |||
Form 4
| -37.69% | -30.00K |
$36.70 | -$1,101,048.96 | 49.6K |
Mar 23
| |||
Form 4
| +44.31% | 31.99K |
$6.00 | $191,940.00 | 104.19K |
Dec 2
| |||
Form 4
| +7.75% | 5.2K |
$9.00 | -$45,745.63 | 72.2K |
May 30
| |||
Form 4
| +14.37% | 8.42K |
—
|
—
| 67K |
May 21 - May 23
| |||
Form 4
| +28.27% | 12.91K |
—
|
—
| 58.58K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +80.45% | 20.36K |
—
|
—
| 45.67K |
May 25 - May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +87.28% | 11.79K |
—
|
—
| 25.31K |
May 21
| |||
Form 4
| +67.11% | 40K |
$4.03 | $161,388.00 | 99.6K |
May 13
| |||
Form 4
| +50.51% | 20K |
$4.63 | $92,512.00 | 59.6K |
Jan 11
| |||
Form 4
| +102.04% | 20K |
$7.25 | $144,926.53 | 39.6K |
Dec 10 - Dec 11
| |||
Form 4
| -50.00% | -13.51K |
$7.51 | -$101,515.06 | 13.51K |
Scheduled
|
May 27
| ||
Form 4
|
∞
| 27.03K |
—
|
—
| 27.03K |
May 21 - May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +434.78% | 20K |
$5.15 | $103,022.00 | 24.6K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 4.6K |
$10.97 | $50,462.00 | 4.6K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENOPTIX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.73% | -501.00 |
$25.00 | -$12,525.00 | 4.17K |
Feb 25
| |||
Form 4
| -3.43% | -166.00 |
$16.93 | -$2,810.38 | 4.67K |
Dec 1
| |||
Form 4
| -3.32% | -166.00 |
$17.70 | -$2,938.20 | 4.83K |
Sep 1
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tricida, Inc. No price found
COO, CFO and EVP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| -2.13% | -1.38K |
$9.56 | -$13,231.04 | 63.62K |
Dec 31
| |||
Form 4
| +175.44% | 166.67K |
$6.00 | $1,000,002.00 | 261.67K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +60.00% | 15K |
$6.78 | $101,700.00 | 40K |
Dec 10
| |||
Form 4
| +7.04% | 4K |
—
|
—
| 60.84K |
Sep 10
| |||
Form 4
| +58.33% | 35K |
$30.09 | $1,053,203.37 | 95K |
May 11 - May 12
| |||
Form 4
| +10.00% | 5K |
$29.46 | $147,300.00 | 55K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +66.67% | 20K |
$34.30 | $686,015.80 | 50K |
Nov 18 - Nov 19
| |||
Form 4
| +3,061.80% | 54.35K |
$1.84 | $99,998.48 | 56.12K |
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
∞
| 30K |
$32.33 | $969,869.92 | 30K |
Aug 12 - Aug 13
| |||
Form 4
| +400.00% | 20K |
$36.00 | $720,000.00 | 25K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +8.33% | 5K |
$29.72 | $148,600.00 | 65K |
Nov 13
| |||
Form 4
|
∞
| 60K |
$19.00 | $1,140,000.00 | 60K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||